AVITA CFO acquires 5,000 shares via ESPP
AVITA Medical, Inc. CFO David D. O'Toole acquired 5,000 shares of common stock in a Form 4 transaction.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
AVITA Medical, Inc. CFO David D. O'Toole acquired 5,000 shares of common stock in a Form 4 transaction. The shares were obtained through the company’s Employee Share Purchase Plan at $3.0515 per share, based on an 85% discount to the December 1, 2025 closing price. Following this acquisition, he directly holds 150,927 shares, including unvested RSUs.
Insider Trade Summary
Grant/Award: 5,000 shares
Grant/Award
1 txn
Insider
O'Toole David D
Role
CFO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 5,000 | $3.0515 | $15K |
Holdings After Transaction:
Common Stock — 150,927 shares (Direct)
Holdings Before and After:
Common Stock, 145,927 to 150,927 shares (Direct)
Footnotes (2)
- F1. These shares were acquired under the AVITA Medical, Inc. Employee Share Purchase Plan ("ESPP") for the ESPP purchase period beginning on December 1, 2025 and ended on May 31, 2026 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on December 1, 2025 (the purchase date of the offering period).
- F2. Includes unvested RSUs
Key Figures
Shares acquired: 5,000 shares
Acquisition price: $3.0515 per share
Post-transaction holdings: 150,927 shares
+2 more
5 metrics
Shares acquired
5,000 shares
Common stock acquired on May 29, 2026
Acquisition price
$3.0515 per share
ESPP purchase price
Post-transaction holdings
150,927 shares
Direct ownership after acquisition, includes unvested RSUs
ESPP discount
85% of closing price
Based on December 1, 2025 closing stock price
Transaction code
A (grant, award, or other acquisition)
Non-derivative acquisition of common stock
Key Terms
Employee Share Purchase Plan, Rule 16b-3(d), Rule 16b-3(c), RSUs
4 terms
Rule 16b-3(d) regulatory
"in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)"
Rule 16b-3(d) is a narrow SEC safe-harbor that shields company insiders (officers, directors and large shareholders) from liability for short‑swing profits when their buys or sells of company stock are made under a pre-established, written plan or contract that removes the insider’s ability to time trades. For investors, this matters because it permits predictable, automated insider transactions — like scheduled sales for diversification or payroll withholding — without triggering forced disgorgement, so such planned trades are treated differently from opportunistic insider trading.
Rule 16b-3(c) regulatory
"in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c)"
An SEC rule that lets corporate insiders avoid automatic "short‑swing" profit recovery when they buy or sell their company’s stock under a pre‑approved, written plan that meets specific conditions. For investors, it matters because it clarifies when insider trades are treated as routine, reducing legal uncertainty and helping distinguish trades made for ordinary compensation or pre‑planned reasons from those that might signal opportunistic or timely insider advantage.
RSUs financial
"Includes unvested RSUs"
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did AVITA Medical (RCEL) disclose in this Form 4 filing?
AVITA Medical reported that its CFO, David D. O'Toole, acquired 5,000 shares of common stock. The shares were obtained through the Employee Share Purchase Plan at $3.0515 per share, increasing his direct holdings to 150,927 shares, including unvested RSUs.
What are the CFO’s total AVITA Medical (RCEL) holdings after this transaction?
After the ESPP acquisition, CFO David D. O'Toole directly owns 150,927 AVITA Medical shares. This total includes unvested restricted stock units (RSUs), as noted in the filing footnotes, and reflects his position following the 5,000-share Employee Share Purchase Plan purchase.
AI-generated analysis. How Rhea-AI works. Not financial advice.
